🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
Phase 2a study to assess the safety and efficacy of IV infused spray-dried ...
Status
Terminated
Location
University of Arizona
Start Date
2018-12-14
Trial ID
NCT03700723
Treatments Being Tested
The primary objective of the Single Rising Dose (SRD) part (trial part 1) i...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2017-01-12
Trial ID
NCT03004404
PREMIERE parallel, non-comparative, two-arm, randomized 1:1, open-label, mu...
Status
Recruiting
Location
ICO Badalona
Start Date
2023-02-03
Trial ID
NCT05982093
Treatments Being Tested
The study is designed as a Phase III, double-blind, multi-center, randomize...
Status
Unknown
Location
Center for Vaccine Development
Start Date
2022-09-16
Trial ID
NCT05447377
Treatments Being Tested
This is a single-center, randomized, open-label, parallel-controlled clinic...
Status
Recruiting
Location
Department of Critical Care Medicine of Zhujiang Hospital,Southern Medical University
Start Date
2026-04-07
Trial ID
NCT07469072
Treatments Being Tested
This study is designed to evaluate the safety and efficacy of NLC-V in pati...
Status
Completed
Location
Shaare Zedek Hospital
Start Date
2021-01-30
Trial ID
NCT05226767
Treatments Being Tested
The aim of tis study is to assess the efficacy and safety of Jarsin® 300 mg...
Status
Completed
Location
Multiple Locations
Start Date
2002-12
Trial ID
NCT00861978
Treatments Being Tested
The effects of endocrine disruptors (EDs) are well known. Therefore, the ai...
Status
Unknown
Location
Multiple Locations
Start Date
2024-06-20
Trial ID
NCT06088238
This is a prospective observational trial that will enroll pregnant women b...
Status
Completed
Location
Prof. Dr. Daniel Surbek
Start Date
2013-12
Trial ID
NCT02092688
Treatments Being Tested